77.56
                                            前日終値:
              $76.69
            開ける:
              $76.65
            24時間の取引高:
                1.90M
            Relative Volume:
              0.26
            時価総額:
                $98.37B
            収益:
              $386.46B
            当期純損益:
              $4.49B
            株価収益率:
              21.64
            EPS:
                3.5841
            ネットキャッシュフロー:
                $4.78B
            1週間 パフォーマンス:
              -5.24%
            1か月 パフォーマンス:
              +2.98%
            6か月 パフォーマンス:
                +16.38%
            1年 パフォーマンス:
              +37.50%
            Cvs Health Corp Stock (CVS) Company Profile
CVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                CVS
                            
                             Cvs Health Corp | 77.56 | 97.35B | 386.46B | 4.49B | 4.78B | 3.5841 | 
|   
                          
                                UNH
                            
                             Unitedhealth Group Inc | 345.09 | 312.29B | 435.16B | 18.37B | 17.37B | 19.16 | 
|   
                          
                                ELV
                            
                             Elevance Health Inc | 317.72 | 71.55B | 194.82B | 5.53B | 3.77B | 24.45 | 
|   
                          
                                CI
                            
                             Cigna Group | 246.15 | 65.99B | 261.22B | 5.40B | 3.94B | 18.31 | 
|   
                          
                                HUM
                            
                             Humana Inc | 283.06 | 34.35B | 123.11B | 1.58B | 2.44B | 13.03 | 
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 | 
|---|---|---|---|
| 2025-10-14 | 開始されました | Goldman | Buy | 
| 2025-08-18 | アップグレード | UBS | Neutral → Buy | 
| 2025-08-14 | アップグレード | Robert W. Baird | Neutral → Outperform | 
| 2025-02-13 | アップグレード | Leerink Partners | Market Perform → Outperform | 
| 2025-02-12 | アップグレード | Cantor Fitzgerald | Neutral → Overweight | 
| 2025-01-30 | アップグレード | Edward Jones | Hold → Buy | 
| 2024-12-03 | アップグレード | Deutsche Bank | Hold → Buy | 
| 2024-11-18 | アップグレード | Wells Fargo | Equal Weight → Overweight | 
| 2024-10-10 | アップグレード | Barclays | Equal Weight → Overweight | 
| 2024-10-04 | アップグレード | TD Cowen | Hold → Buy | 
| 2024-05-30 | 開始されました | Robert W. Baird | Neutral | 
| 2024-05-07 | ダウングレード | TD Cowen | Buy → Hold | 
| 2024-05-02 | ダウングレード | UBS | Buy → Neutral | 
| 2024-05-01 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral | 
| 2024-05-01 | ダウングレード | Leerink Partners | Outperform → Market Perform | 
| 2024-03-06 | 開始されました | Barclays | Equal Weight | 
| 2024-02-26 | 開始されました | Leerink Partners | Outperform | 
| 2023-12-22 | 開始されました | HSBC Securities | Buy | 
| 2023-09-19 | アップグレード | Evercore ISI | In-line → Outperform | 
| 2023-09-12 | アップグレード | Wolfe Research | Peer Perform → Outperform | 
| 2023-08-18 | ダウングレード | Edward Jones | Buy → Hold | 
| 2023-05-26 | 開始されました | Piper Sandler | Overweight | 
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight | 
| 2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line | 
| 2022-11-23 | 再開されました | Morgan Stanley | Overweight | 
| 2022-06-17 | 開始されました | Loop Capital | Buy | 
| 2022-05-27 | ダウングレード | Bernstein | Outperform → Mkt Perform | 
| 2022-03-29 | ダウングレード | Deutsche Bank | Buy → Hold | 
| 2022-02-11 | ダウングレード | Raymond James | Strong Buy → Outperform | 
| 2021-12-14 | 開始されました | Goldman | Buy | 
| 2021-12-01 | 開始されました | Seaport Research Partners | Buy | 
| 2021-05-19 | 開始されました | Wells Fargo | Equal Weight | 
| 2021-03-17 | ダウングレード | Guggenheim | Buy → Neutral | 
| 2021-01-08 | アップグレード | Jefferies | Hold → Buy | 
| 2020-09-17 | 開始されました | Piper Sandler | Overweight | 
| 2020-07-01 | 開始されました | SVB Leerink | Mkt Perform | 
| 2020-05-14 | アップグレード | Credit Suisse | Neutral → Outperform | 
| 2019-09-27 | 再開されました | RBC Capital Mkts | Outperform | 
| 2019-09-12 | 開始されました | Deutsche Bank | Buy | 
| 2019-06-05 | アップグレード | Standpoint Research | Hold → Buy | 
| 2019-04-29 | ダウングレード | Credit Suisse | Outperform → Neutral | 
| 2019-04-18 | 開始されました | Guggenheim | Buy | 
| 2019-04-15 | ダウングレード | Oppenheimer | Outperform → Perform | 
| 2019-04-10 | 繰り返されました | BofA/Merrill | Buy | 
| 2019-03-13 | 開始されました | Bernstein | Outperform | 
| 2019-02-20 | ダウングレード | Wells Fargo | Outperform → Market Perform | 
| 2019-01-17 | 開始されました | UBS | Buy | 
| 2018-12-18 | 開始されました | Barclays | Overweight | 
| 2018-11-29 | 再開されました | Goldman | Neutral | 
| 2018-11-28 | 開始されました | Evercore ISI | Outperform | 
| 2018-10-26 | 再開されました | Wolfe Research | Peer Perform | 
| 2018-07-09 | アップグレード | Citigroup | Neutral → Buy | 
| 2018-02-27 | 再開されました | BofA/Merrill | Buy | 
| 2018-02-13 | 繰り返されました | Citigroup | Neutral | 
                    すべてを表示
                     
                  
                Cvs Health Corp (CVS) 最新ニュース
Impact Partnership Wealth LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Carret Asset Management LLC - MarketBeat
CVS Health Corporation $CVS Stock Position Trimmed by Daymark Wealth Partners LLC - MarketBeat
Is CVS Health Corporation (Common Stock) (CVS0) stock a safe buy pre earnings2025 Market Overview & Daily Oversold Bounce Ideas - newser.com
Is CVS Health Corporation stock in correction or buying zoneMarket Performance Summary & Accurate Intraday Trading Signals - newser.com
Is CVS Health Corporation stock positioned for digital transformationEarnings Miss & AI Driven Stock Price Forecasts - newser.com
Will CVS Health Corporation (CVS) stock maintain strong growth2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Is CVS Health Corporation stock a top momentum playJuly 2025 Short Interest & Short-Term High Return Strategies - newser.com
Philly Accuses PBMs Of Knowingly Enabling Opioid Crisis - Law360
CVS Health to shut down 16 ‘underperforming' Oak Street Health clinics, including 1 in Chicago - MSN
CVS Stock Slips as $5.7 Billion Charge Overshadows Record Results - Yahoo! Finance Canada
CVS Stock: Evercore ISI Raises Price Target to $95, Maintains Ou - GuruFocus
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
CVS Health Grows Earnings And Outlook While Stock Stumbles - Finimize
Why CVS Health (CVS) Stock Is Falling Today - Barchart.com
CVS Health Corp (CVS) Q3 2025 Earnings Call Highlights: Strong R - GuruFocus
CVS Health to shut down 16 Oak Street Health clinics, including 1 in Chicago - NBC 5 Chicago
CVS Health Corp. Hits New 52-Week High of $85.15 - Markets Mojo
CVS Health (CVS) Rating Maintained by RBC Capital with Raised Pr - GuruFocus
CVS Health (CVS): Cantor Fitzgerald Raises Price Target to $95 | - GuruFocus
CVS Health (CVS) Analyst Rating Update: Target Price Raised by T - GuruFocus
CVS Health Stock Feels the Heat as $5.7B Write-Down Weighs on ‘Record’ Q3 - TipRanks
CVS Health Corporation (NYSE:CVS) Q3 2025 Earnings Call Transcript - Insider Monkey
Jennison Associates LLC Purchases 2,117,798 Shares of CVS Health Corporation $CVS - MarketBeat
CT health system, major insurer at odds over new contract. What it could mean for patients. - Hartford Courant
Is it time to cut losses on CVS Health CorporationEarnings Risk Report & Long-Term Investment Growth Plans - newser.com
CVS Health tops Q3 forecasts but absorbs hefty charge for struggling clinic business - WPRI.com
CVS Q3 Deep Dive: Pharmacy Gains, Aetna Turnaround, and PBM Transition Shape Outlook - Yahoo! Finance Canada
CVS Health Reports Record Revenue Despite Impairment - TipRanks
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight - GuruFocus
Pharmacies Say $1.5B Damages Too Much In Fla. Opioid Suit - Law360
Short interest data insights for CVS Health CorporationJuly 2025 Fed Impact & Daily Growth Stock Tips - newser.com
UBS Turns More Bullish on CVS Health (CVS) with $96 Price Target - Insider Monkey
CVS Health Earnings Call Highlights Robust Growth and Strategic Adjustments - TipRanks
CVS Health tops third-quarter forecasts but absorbs hefty charge for struggling clinic business - The Boston Globe
CVS Health posts record Q3 revenue despite $5.7B write-down - The Business Journals
CVS Health forecasts double-digit earnings growth for 2026 - Yahoo! Finance Canada
CVS Health (NYSE:CVS) Hits New 12-Month HighTime to Buy? - MarketBeat
CVS Posts Strong Q3 Earnings, but Shares Show Little Movement - AOL.com
CVS Health Earnings: Turnaround Efforts Proceeding and Could Continue Boosting Profits in 2026 - Morningstar
CVS Health (CVS) Raises Full-Year 2025 Earnings Guidance - GuruFocus
CVS Health reports Q3 earnings beat, raises full-year guidance - Proactive financial news
CVS Health rethinks Oak Street Health strategy, raises guidance - Modern Healthcare
CVS Q3 tops Street but takes $5.3B charge on struggling health care delivery unit - Chain Store Age
CVS Health Delivers Confident Outlook After Q3 Performance, Stock Hits 52-Week High - Benzinga
CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up - The Globe and Mail
CVS Prioritizes Membership Growth Over Expanding Clinic Numbers - GuruFocus
CVS Boosts 2025 Profit Outlook Third Time on Insurance Gains - Bloomberg.com
CVS Health Corp reports results for the quarter ended September 30Earnings Summary - TradingView
CVS Health (CVS) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo! Finance Canada
CVS to Scale Back Oak Street Clinic Expansions - GuruFocus
Cvs Health Corp (CVS) 財務データ
収益
当期純利益
現金流量
EPS
                大文字化:
                 
                  | 
                ボリューム (24 時間):
                 
            
         
                     
                             ストックスクリーナーアプリを入手
                    ストックスクリーナーアプリを入手